Article
West Conshohocken, Pa. -- Dermisonics Inc., a developer of ultrasonic transdermal drug delivery technologies, announced that it has completed the first working model of its A-Wand antiseptic delivery system and is in talks with the Army Institute of Surgical Research under the Combat Casualty Care Research Program to develop a battlefield version.
West Conshohocken, Pa. - Dermisonics Inc., a developer of ultrasonic transdermal drug delivery technologies, announced that it has completed the first working model of its A-Wand antiseptic delivery system and is in talks with the Army Institute of Surgical Research under the Combat Casualty Care Research Program to develop a battlefield version.
The A-Wand is a handheld ultrasonic device for applying antiseptic solutions to cuts, abrasions and wounds and includes a replaceable Patch-Cap, which holds up to 40 ml of antiseptic solution. It uses alternating ultrasonic waves to enlarge skin pores, which in turn enables antiseptics to permeate into the dermis through the sweat pores.
A company spokesman said the A-Wand could be used by medics in the field, by military medical units and for follow-up wound care. The spokesman said that in addition to the military, major pharmaceutical companies and medical institutions have expressed interest in the device.